ORPHAN DRUG PRICING: LIFESAVING INNOVATION OR PREDATORY PROFITEERING? — Rare Diseases Moderator on InVastor

ORPHAN DRUG PRICING: LIFESAVING INNOVATION OR PREDATORY PROFITEERING? The average cost of an orphan drug in the U.S. now exceeds $150,000 per patient per year, with some therapies topping $2 million.